Oncotarget, Author at Oncotarget.org

Overcoming Aromatase Inhibitor Resistance in Breast Cancer: A New Therapeutic Strategy

The estrogen receptor is overexpressed in and promotes 67-80% and 90% of female and male... read more

January 13, 2026

The OncoExTra® assay (formerly GEM ExTra) is a whole exome, whole transcriptome, tumor-normal genomic profiling... read more

December 15, 2025

Drug repurposing has gained traction as a viable strategy to target dysregulated oncogenic pathways."Colorectal... read more

December 3, 2025

Treg play a deleterious role in the tumor microenvironment by suppressing anti-tumor effector T cells."... read more

November 19, 2025

Preclinical and clinical studies indicate that ferroptosis suppresses tumor growth, and dysregulation of ferroptosis promotes... read more

November 6, 2025

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with poorly characterized molecular... read more

October 22, 2025

In non–small cell lung cancer (NSCLC), alterations in the HER2 (ERBB2) gene define a... read more

October 8, 2025

Heavily pretreated metastatic colorectal cancer (mCRC) poses significant therapeutic challenges."Colorectal cancer is one of... read more

September 24, 2025

Identification and analyses of exceptional responders could eventually offer hints as to why PC is... read more

September 11, 2025

Amivantamab, an anti-EGFR/MET bispecific antibody, shows efficacy in EGFR-mutated NSCLC, but its role in... read more

August 26, 2025